Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet.
Recent reports have demonstrated a potential role of tissue prorenin in the pathogenesis of cardiovascular and renal damage. This study was designed to examine the role of prorenin in the pathogenesis of target organ damage in spontaneously hypertensive rats (SHRs), the best naturally occurring experimental model of essential hypertension. To this end, we studied 20-wk-old male SHRs receiving a normal diet and 8-wk-old male SHRs given food with 8% NaCl. One-half the rats in each group were given prorenin inhibitor (PRAM-1, 0.1 mg.kg(-1).day(-1)) via osmotic minipumps; the other half served as controls. Arterial pressure, left ventricular function, cardiovascular mass indexes, cardiac fibrosis, and renal function were examined at the end of the experiment. Arterial pressure was unaffected by PRAM-1 in rats on either regular or salt-excess diets. In those rats receiving a normal diet, the blockade of prorenin activation consistently reduced left ventricular mass but affected no other variable. Salt-loaded rats given PRAM-1 for 8 wk demonstrated (1) reduced serum creatinine level, (2) decreased left ventricular mass, (3) improved left ventricular function, and (4) reduced left ventricular fibrosis. These data demonstrated that the blockade of nonproteolytic activation of prorenin exerted significant cardiovascular and renal benefit in SHRs with cardiovascular damage produced by salt excess and suggested that the activation of cardiovascular or renal prorenin may be a major mechanism that mediates cardiac and renal damage in this form of accelerated hypertension.
Susic
Dinko
D
Hypertension Research Laboratory, Ochsner Clinic Foundation, 1520 Jefferson Hwy., New Orleans, LA 70121, USA. dsusic@ochsner.org
Zhou
Xiaoyan
X
Frohlich
Edward D
ED
Lippton
Howard
H
Knight
Martha
M
D000595:Amino Acid Sequence; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002320:Cardiovascular Physiological Phenomena / Q000187:drug effects*; D003401:Creatine / Q000097:blood; D004032:Diet; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000235:genetics* / Q000503:physiopathology*; D017379:Hypertrophy, Left Ventricular / Q000517:prevention & control; D017380:Hypertrophy, Right Ventricular / Q000517:prevention & control; D008297:Male; D008969:Molecular Sequence Data; D051381:Rats; D011918:Rats, Inbred SHR; D012982:Sodium, Dietary / Q000009:adverse effects*; D014563:Urodynamics / Q000187:drug effects; D016277:Ventricular Function, Left / Q000187:drug effects / Q000502:physiology; D000092502:Renin Inhibitors
D003401:Creatine; D012982:Sodium, Dietary; D000092502:Renin Inhibitors